Congenital nephrogenic diabetes insipidus;Les diabetes insipides nephrogeniques hereditaires

Medecine/Sciences

Volumn 13, Issue 1, 1997, Pages 11-17

  Bichet, Daniel G ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; VASOPRESSIN RECEPTOR;

ANTIDIURESIS; ARTERIAL BLOOD; ARTICLE; BRAIN; CHROMOSOME XQ; DEHYDRATION; GENE MUTATION; HUMAN; HYPERNATREMIA; HYPERTHERMIA; KIDNEY; KIDNEY FAILURE; KIDNEY TUBULE; MALE; MENTAL DEFICIENCY; NEPHROGENIC DIABETES INSIPIDUS; PERFUSION PRESSURE; PHENOTYPE; TISSUE OXYGENATION; X CHROMOSOME LINKAGE;

EID: 0031047641     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/295     Document Type: Article

References (26)

1. Rittig R, Robertson GL, Siggaard C, et al. Identification of 13 new mutations in the vasopressin-neurophysinII gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 1996; 58: 107-17.
2. Fujiwara TM, Morgan K, Bichet DG. Molecular biology of diabetes insipidus. Annu Rev Med 1995; 46: 331-43.
3. Deen PMT, Verdijk MAJ, Knoers NVAM, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264: 92-5.
4. Van Lieburg AF, Verdijk MAJ, Knoers NVAM, et al. Patients with autosomal nephrogenic diabetes insipidus: homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 1994; 55: 648-52.
5. Knepper MA, Rector FC. Urinary concentration and dilution. In: Brenner BM, ed. The kidney, vol. I, 5th ed. Philadelphia: W.B. Saunders Company, 1996: 532-70.
6. Thibonnier M, Auzan C, Madhun Z, et al. Molecular cloning, sequencing, and functional expression of cDNA encoding the human V1a vasopressin receptor. J Biol Chem 1994; 269: 3304-10.
7. Sugimoto T, Saito M. Mochizuki S, et al. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-92.
8. De Keyzer Y, Auzan C, Lenne F, et al. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 1994; 356: 215-20.
9. Bichet DG, Razi M, Lonergan M, et al. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine]vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988; 318: 881-7.
10. Latronico AC, Anasti J, Arnhold IJP, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 334: 507-12.
11. Nielsen S, Agre P. The aquaporin family of water channels in kidney. Kidney Int 1995; 48: 1057-68.
12. Cooper DN, Krawczak M, Antaonarakis SE. The nature and mechanisms of human gene mutation. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, vol. 1, 7th ed. New York: McGraw-Hill Inc, 1995: 259-91.
13. Bichet DG. Nephrogenic diabetes insipidus. In : Cameron JS, Davison AM, Grünfeld JP, Kerr DNS, Ritz E, eds. Oxford textbook of clinical nephrology. New York: Oxford University Press, 1992: 789-800.
14. Bichet DG, Arthus MF, Lonergan M, et al. Autosomal dominant and autosomal recessive nephrogenic diabetes insipidus: novel mutations in the AQP2 gene. J Am Soc Nephrol 1995; 6: 717.
15. Benoit E, Méry P, Tacnet F, Tell F. Histoires d'aquaporines: des canaux qui font couler beaucoup d'eau. Med Sci 1996; 12: 787-94.
16. Südhof TC. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995; 375: 645-53.
17. Bichet DG, Hendy GN, Lonergan M, et al. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet 1992; 51: 1089-102.
18. Bichet DG, Arthus MF, Lonergan M, et al. X-linked nephrogenic diabetes insipidus mutations in North American and the Hopewell hypothesis. J Clin Invest 1993; 92: 1262-8.
19. Fujiwara MT, Morgan K, Bichet DG. Invited Commentary: molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 1997 (sous presse).
20. Tsukaguchi H, Matsubara H, Taketani S, et al. Binding-defective, intracellular transport-defective, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest 1995; 96: 2043-50.
21. 2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996; 15: 1283-91.
22. Bockaert J. Les récepteurs à sept domaines transmembranaires: physiologie et pathologie de la transduction. Med Sci 1995; 11: 382-94.
23. Birnbaumer M. Mutations and diseases of G protein coupled receptors. J Recept Sign Transd Res 1995; 15: 131-60.
24. 2 specific response. J Am Soc Nephrol 1991; 2: 723.
25. Sharif M, Hanley MR. Stepping up the pressure. Nature 1992; 357: 279-80.
26. Jung JS, Preston GM, Smith BL, Guggino WB, Agre P. Molecular structure of the water channel through aquaporin CHIP: the hourglass model. J Biol Chem 1994; 269: 14648-54.